Ipsen Unveils Corabotase, First Recombinant Neuroinhibitor RNITM
Ipsen announced Corabotase, the first investigational molecule in the newly designated class of recombinant neuroinhibitors called RNITM, recognized by the WHO and USAN. The announcement was made at the SCALE Symposium and the molecule is currently in Phase II trials.
Menafn·


